NS-1: a novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile.
Eur J Pharmacol.
2012 Jun 5;684(1-3):154-60. doi: 10.1016/j.ejphar.2012.03.033. Epub 2012 Mar 30. PubMed PMID:
22484334.
Comparison of Chemiluminescence vs. Infrared Techniques for Detection of Fetuin-A in Saliva.
Methods Mol Biol.
2015;1314:333-48. doi: 10.1007/978-1-4939-2718-0_34. PubMed PMID:
26139281.
Detection of Blotted Proteins: Not All Blockers Are Created Equal.
Methods Mol Biol.
2015;1314:27-32. doi: 10.1007/978-1-4939-2718-0_4. PubMed PMID:
26139251.
Hypoglycemic agents and potential anti-inflammatory activity.
J Inflamm Res.
2016;9:27-38. doi: 10.2147/JIR.S86917. eCollection 2016. Review. PubMed PMID:
27114714; PubMed Central PMCID:
PMC4833364.
High fat diet induces brain insulin resistance and cognitive impairment in mice.
Biochim Biophys Acta Mol Basis Dis.
2017 Feb;1863(2):499-508. doi: 10.1016/j.bbadis.2016.10.006. Epub 2016 Oct 19. PubMed PMID:
27771511.
Liver Kinase B1 Links Macrophage Metabolism Sensing and Atherosclerosis.
Circ Res.
2017 Oct 13;121(9):1024-1026. doi: 10.1161/CIRCRESAHA.117.311923. PubMed PMID:
29025752; PubMed Central PMCID:
PMC5679459.
High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.
Arterioscler Thromb Vasc Biol.
2018 Feb;38(2):e10-e16. doi: 10.1161/ATVBAHA.117.310222. Review. PubMed PMID:
29367232; PubMed Central PMCID:
PMC5804739.
A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome.
Diabetes.
2018 May;67(5):946-959. doi: 10.2337/db17-0744. Epub 2018 Feb 26. PubMed PMID:
29483182; PubMed Central PMCID:
PMC5909997.
Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance.
Am J Physiol Endocrinol Metab.
2019 Aug 1;317(2):E250-E260. doi: 10.1152/ajpendo.00089.2018. Epub 2019 May 14. PubMed PMID:
31084489.
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.
Arterioscler Thromb Vasc Biol.
2019 Dec;39(12):e253-e272. doi: 10.1161/ATVBAHA.119.313253. Epub 2019 Oct 3. PubMed PMID:
31578081; PubMed Central PMCID:
PMC6879856.
Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques".
Arterioscler Thromb Vasc Biol.
2020 Feb;40(2):e33-e34. doi: 10.1161/ATVBAHA.119.313737. Epub 2020 Jan 22. PubMed PMID:
31967903; PubMed Central PMCID:
PMC8177970.
A New Treatment Strategy for Diabetic Dyslipidemia?.
Diabetes.
2020 Oct;69(10):2061-2063. doi: 10.2337/dbi20-0035. PubMed PMID:
32958608; PubMed Central PMCID:
PMC7506828.
Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
Circ Res.
2020 Oct 9;127(9):1198-1210. doi: 10.1161/CIRCRESAHA.120.317178. Epub 2020 Aug 21. PubMed PMID:
32819213; PubMed Central PMCID:
PMC7554159.
ADAM17 Boosts Cholesterol Efflux and Downstream Effects of High-Density Lipoprotein on Inflammatory Pathways in Macrophages.
Arterioscler Thromb Vasc Biol.
2021 Jun;41(6):1854-1873. doi: 10.1161/ATVBAHA.121.315145. Epub 2021 Apr 22. PubMed PMID:
33882688; PubMed Central PMCID:
PMC8159900.
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
J Clin Invest.
2021 Nov 15;131(22). doi: 10.1172/JCI153285. PubMed PMID:
34491909; PubMed Central PMCID:
PMC8592537.
What would you like to do?